Search Results - "Meillon, Luis Antonio"
-
1
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
Published in Current oncology reports (06-10-2020)“…Purpose of Review Acute myeloid leukemia (AML) is a costly disease, and its impact is greater in developing countries (DC). We will review the current concept…”
Get full text
Journal Article -
2
Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA)
Published in Cancer medicine (Malden, MA) (01-06-2018)“…Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the clonal expansion of hematopoietic lymphoid progenitors. With new target…”
Get full text
Journal Article -
3
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival
Published in Cancer investigation (21-10-2015)“…This is the largest Latin American study of BCR-ABL mutations in chronic myeloid leukemia (CML) patients, resistant to imatinib (IM). In 195/467 (41%)…”
Get full text
Journal Article -
4
Anticoagulant Proteins in a Population of Mexican Mestizo Donors
Published in Annals of vascular surgery (01-02-2015)“…Background To determine the activity of antithrombin (AT), protein C (PC), and protein S (PS), as well as the frequency of deficiencies of these proteins in a…”
Get full text
Journal Article -
5
Imatinib Mesylate (IM) Versus IM + Low Dose of Pegylated Interferon Alfa 2a (Peg-IFN 2a) In Newly-Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML)
Published in Blood (19-11-2010)“…Abstract 4497 IM 400mg daily is the current standard of treatment of CP CML. Almost 70% of patients achieve complete cytogenetic response (CCR) at 12 months…”
Get full text
Journal Article -
6
-
7
Primary immune thrombocytopenia in adults in Mexico: national characteristics and the relation to international literature
Published in Gaceta médica de México (01-07-2014)“…In order to identify the clinical approach of a sample of Mexican hematologists for primary immune thrombocytopenia (ITP) in adults in Mexico, we applied an…”
Get full text
Journal Article -
8
Compassionate Use of Nilotinib (AMN107) in Mexican Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib
Published in Blood (16-11-2007)“…Background: Nilotinib is a novel tyrosine kinase inhibitor(TKI) developed for the treatment of Ph+ CML patients(pts) with intolerance or resistance to…”
Get full text
Journal Article -
9
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival
Published in Cancer investigation (2015)“…This is the largest Latin American study of BCR-ABL mutations in chronic myeloid leukemia (CML) patients, resistant to imatinib (IM). In 195/467 (41%)…”
Get full text
Journal Article -
10
-
11
Hemoglobin and Platelet Count Effect on Platelet Yields in Plateletpheresis
Published in Archives of medical research (01-03-2003)“…Platelet transfusion in thrombocytopenic patients, especially those with marrow failure, remains one of the most important support measures available…”
Get full text
Journal Article -
12
First inter-institutional consensus on Chronic Myeloproliferative Neoplasms
Published in Gaceta médica de México (01-09-2023)Get full text
Journal Article -
13
Pregnancy in myeloproliferative neoplasms
Published in Gaceta médica de México (01-09-2022)Get full text
Journal Article -
14
-
15
-
16
Risks in invasive procedures
Published in Gaceta médica de México (01-09-2022)Get full text
Journal Article -
17
Myelofibrosis: diagnosis and treatment
Published in Gaceta médica de México (01-09-2022)Get full text
Journal Article -
18
-
19
Transplantation of hematopoietic progenitors in myelofibrosis
Published in Gaceta médica de México (01-01-2022)Get full text
Journal Article -
20
Essential thrombocythaemia
Published in Gaceta médica de México (01-01-2022)Get full text
Journal Article